Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
New oral anticoagulants (NOACs) are now widely used for the prevention and treatment of venous thrombosis, and for the prevention of stroke and systemic embolism in patients with atrial fibrillation. As compared with warfarin, NOACs have the advantage of rapid onset of action and less drug interacti...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Yong Chan Lee,
2018-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|